Evidence map›Paper›PMID 38106647›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2022

Invasive group A streptococcal disease surveillance in Canada, 2020.

Alyssa Golden, Averil Griffith, Walter Demczuk, Gregory Tyrrell, Julianne Kus, Allison McGeer, Marc-Christian Domingo, Linda Hoang, Jessica Minion, Paul Van Caeseele and 9 more

Open access · diamondAbstract read
PubMed Full text at PMC
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Increase of macrolide resistance amongAntimicrobial agents and chemotherapy · 2025
    Article
  4. Article
  5. Article
  6. Invasive group A streptococcal disease surveillance in Canada, 2021-2022.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  7. Invasive group A streptococcal (iGAS) surveillance in Island Health, British Columbia, 2022.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 4 countries.

Alyssa GoldenNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Averil GriffithNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Walter DemczukNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Gregory TyrrellProvincial Laboratory for Public Health (Microbiology), Edmonton, AB.
Julianne KusPublic Health Ontario, Toronto, ON.
Allison McGeerToronto Invasive Bacterial Diseases Network (TIBDN), Department of Microbiology, Mount Sinai Hospital, Toronto, ON.
Marc-Christian DomingoLaboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de- Bellevue, QC.
Linda HoangBritish Columbia Centre for Disease Control, Vancouver, BC.
Jessica MinionRoy Romanow Provincial Laboratory, Regina, SK.
Paul Van CaeseeleCadham Provincial Laboratory, Winnipeg, MB.
Hanan SmadiNew Brunswick Department of Health, Fredericton, NB.
David HaldaneQueen Elizabeth II Health Science Centre, Halifax, NS.
George ZahariadisNewfoundland and Labrador Public Health Laboratory, St. John's, NL.
Kristen MeadQueen Elizabeth Hospital, Charlottetown, PE.
Laura StevenStanton Territorial Hospital Laboratory, Yellowknife, NT.
Lori StrudwickYukon Communicable Disease Control, Whitehorse, YT.
Anita LiCentre for Immunization & Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Michael MulveyNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Irene MartinNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Public Health Agency of Canada · CABC Centre for Disease Control · CAGovernment of New Brunswick · CAInstitut National de Santé Publique · CIMount Sinai Hospital · CAProvincial Laboratory of Public Health · CAQueen Elizabeth Hospital · BBQueen Elizabeth II Health Sciences Centre · CASaskatchewan Disease Control Laboratory · CASt. John's School · USUniversity of Toronto · CAYukon Health and Social Services · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Invasive group A streptococcal (iGAS) disease (caused by Methods: The Public Health Agency of Canada's National Microbiology Laboratory (Winnipeg, Manitoba) collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive Results: Overall, the incidence of iGAS disease in Canada has increased from 4.0 to 8.1 cases per 100,000 population from 2009 to 2019. The 2019 incidence represents a slight decrease from the 2018 rate of 8.6 cases per 100,000 population. A total of 2,867 invasive Conclusion: Though the number of collected invasive

Indexed as

antimicrobial resistanceCanadaemmgroup A streptococcusiGASStreptococcus pyogenessurveillance

Identifiers

PMID38106647
PMCPMC10723789
OpenAlexW4297878754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.